BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36789646)

  • 1. Analysis of the TSER and G>C variants in the
    Favela-Mendoza AF; Godínez-López AD; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortes G; Rangel-Villalobos H
    Ann Hum Biol; 2023 Feb; 50(1):94-99. PubMed ID: 36789646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.
    Pastorakova A; Chandogova D; Chandoga J; Luha J; Bohmer D; Malova J; Braxatorisova T; Juhosova M; Reznakova S; Petrovic R
    Neoplasma; 2017; 64(6):962-970. PubMed ID: 28895423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.
    Cho HJ; Park YS; Kang WK; Kim JW; Lee SY
    Ther Drug Monit; 2007 Apr; 29(2):190-6. PubMed ID: 17417073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
    Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-dependent association of
    Ioannou C; Ragia G; Balgkouranidou I; Xenidis N; Amarantidis K; Koukaki T; Biziota E; Kakolyris S; Manolopoulos VG
    Pharmacogenomics; 2021 Jul; 22(11):669-680. PubMed ID: 34100299
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
    Meulendijks D; Jacobs BA; Aliev A; Pluim D; van Werkhoven E; Deenen MJ; Beijnen JH; Cats A; Schellens JH
    Int J Cancer; 2016 Jan; 138(1):245-53. PubMed ID: 26189437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
    Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
    Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase pharmacogenetics in colorectal cancer.
    Marsh S; McLeod HL
    Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.
    Thomas F; Hoskins JM; Dvorak A; Tan BR; McLeod HL
    Pharmacogenomics; 2010 Dec; 11(12):1751-6. PubMed ID: 21142919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
    Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Mexican population.
    Quintero-Ramos A; Gutiérrez-Rubio SA; Del Toro-Arreola A; Franco-Topete RA; Oceguera-Villanueva A; Jiménez-Pérez LM; Castro-Cervantes JM; Barragán-Ruiz A; Vázquez-Camacho JG; Daneri-Navarro A
    Genet Mol Res; 2014 Oct; 13(4):8749-56. PubMed ID: 25366766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TYMS and DPYD polymorphisms in a Turkish population.
    Süzen HS; Yüce N; Güvenç G; Duydu Y; Erke T
    Eur J Clin Pharmacol; 2005 Dec; 61(12):881-5. PubMed ID: 16328315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Hitre E; Budai B; Adleff V; Czeglédi F; Horváth Z; Gyergyay F; Lövey J; Kovács T; Orosz Z; Láng I; Kásler M; Kralovánszky J
    Pharmacogenet Genomics; 2005 Oct; 15(10):723-30. PubMed ID: 16141798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase enhancer region: Novel allele in Indians.
    Dhawan D; Padh H
    Ann Hum Biol; 2017 Feb; 44(1):87-90. PubMed ID: 27009482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G>C SNP of thymidylate synthase with respect to colorectal cancer.
    Gusella M; Padrini R
    Pharmacogenomics; 2007 Aug; 8(8):985-96. PubMed ID: 17716232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer.
    Marsh S; McKay JA; Cassidy J; McLeod HL
    Int J Oncol; 2001 Aug; 19(2):383-6. PubMed ID: 11445856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies.
    Schaerer D; Froehlich TK; Hamzic S; Offer SM; Diasio RB; Joerger M; Amstutz U; Largiadèr CR
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33086767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.